1. Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models.
- Author
-
Yamamoto E, Watanabe S, Bao B, Watanabe H, Nakatsuma K, Izuhara M, Ono K, Nakazawa G, Kimura T, and Saito N
- Subjects
- Animals, Cardiac Catheterization adverse effects, Cardiovascular Agents chemistry, Cardiovascular Agents pharmacokinetics, Cell Proliferation drug effects, Coronary Angiography, Coronary Restenosis diagnostic imaging, Coronary Restenosis metabolism, Coronary Restenosis pathology, Dimethylpolysiloxanes chemistry, Disease Models, Animal, Drug Carriers chemistry, Endothelial Cells drug effects, Endothelial Cells metabolism, Female, Iliac Artery diagnostic imaging, Iliac Artery metabolism, Iliac Artery pathology, Male, Materials Testing, Myocytes, Smooth Muscle drug effects, Myocytes, Smooth Muscle metabolism, Myocytes, Smooth Muscle pathology, Paclitaxel chemistry, Paclitaxel pharmacokinetics, Percutaneous Coronary Intervention adverse effects, Prosthesis Design, Rabbits, Sus scrofa, Time Factors, Tomography, Optical Coherence, Cardiac Catheterization instrumentation, Cardiac Catheters, Cardiovascular Agents administration & dosage, Coated Materials, Biocompatible, Coronary Restenosis surgery, Iliac Artery surgery, Nanoparticles, Paclitaxel administration & dosage, Percutaneous Coronary Intervention instrumentation
- Abstract
Background: The main drawback of current available drug coated balloons (DCB) is that a certain percentage of the coated drug is lost in the bloodstream during its delivery to the target lesion. We integrated the nanoparticle-mediated drug delivery technology and polydimethylsiloxane (PDMS) as a new excipient to facilitate an efficient drug delivery and uptake by endothelial cells. The present study aimed to evaluate the efficacy of the new DCB., Method and Results: The novel DCB were coated with 5.6mg of paclitaxel-incorporated nanoparticles using PDMS. The efficacy of the new DCB was examined in rabbit iliac stent model (n=12) and in the swine in-stent restenosis model (n=8) by quantitative coronary angiography (QCA) and optical coherence tomography (OCT). At 28days follow-up in the swine in-stent restenosis model, the area stenosis was significantly lower in DCB group as compared with that of the control group in OCT analysis (0.31±0.05 vs 0.49±0.06, p=0.04) though there was no significant differences observed in the rabbit iliac stent model in QCA and OCT analysis., Conclusion: The study results indicated that the paclitaxel-incorporated nanoparticle-coated balloon using PDMS has an inhibitory effect for the proliferation of smooth muscle cell in a swine coronary in-stent restenosis model., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF